WITTE OWEN N. 4
4 · Allogene Therapeutics, Inc. · Filed Jun 24, 2019
Insider Transaction Report
Form 4
WITTE OWEN N.
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-06+26,025→ 26,025 totalExercise: $25.95Exp: 2029-06-06→ Common Stock (26,025 underlying)
Footnotes (1)
- [F1]The stock option vests in 12 equal monthly installments beginning July 6, 2019.